Product Information

VERAPAMIL 120 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0871 per EA under NDC 00591034510. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Oct 1, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VERAPAMIL 120 MG TABLET

Verapamil Hydrochloride
$0.0871per EA

Strength

120 mg/1

NDC

00591034510

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA070994

FDA Approved

10/1/1986

TE Code

AB

On Market Since

10/1/1986

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL 120 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0871 per EA
All-time high$0.0896 (Jun 10, 2015)
All-time low$0.0564 (Dec 20, 2017)
52-week high$0.0883
52-week low$0.0765
Median price$0.0700
Average price$0.0713
Largest weekly change-26.5% (Jan 18, 2017)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.7%

1M

-0.7%

3M

+5.4%

6M

-0.1%

1Y

+13.8%

3Y

+17.4%

5Y

+31.3%

All

+4.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of VERAPAMIL 120 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 120 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.0871 per EA (NDC 00591034510), effective Aug 19, 2026.

How has the price of VERAPAMIL 120 MG TABLET changed over time?

Over the history we have for it, the NADAC for VERAPAMIL 120 MG TABLET has risen 4.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for VERAPAMIL 120 MG TABLET?

Since Nov 28, 2013, the NADAC for VERAPAMIL 120 MG TABLET has ranged from a low of $0.0564 (Dec 20, 2017) to a high of $0.0896 (Jun 10, 2015), with a median of $0.0700 per EA.

Are there cheaper alternatives to VERAPAMIL 120 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL 120 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures VERAPAMIL 120 MG TABLET?

VERAPAMIL 120 MG TABLET (NDC 00591034510) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.